Package 0924-6020-02

{"route": ["ORAL"], "spl_id": "266e9c9f-2fab-071d-e063-6394a90aa179", "openfda": {"nui": ["N0000000160", "N0000008836", "M0001335", "N0000175722", "N0000175578", "N0000008832"], "unii": ["R16CO5Y76E"], "rxcui": ["211874", "212033"], "spl_set_id": ["f7f9dc46-a945-7ae3-e053-6394a90a1192"], "pharm_class_cs": ["Anti-Inflammatory Agents, Non-Steroidal [CS]"], "pharm_class_pe": ["Decreased Prostaglandin Production [PE]", "Decreased Platelet Aggregation [PE]"], "pharm_class_epc": ["Nonsteroidal Anti-inflammatory Drug [EPC]", "Platelet Aggregation Inhibitor [EPC]"], "pharm_class_moa": ["Cyclooxygenase Inhibitors [MoA]"], "manufacturer_name": ["Acme United Corporation"]}, "finished": true, "packaging": [{"sample": false, "description": "50 PACKET in 1 CARTON (0924-6020-02)  / 2 TABLET in 1 PACKET", "package_ndc": "0924-6020-02", "marketing_start_date": "20230331"}], "brand_name": "Bayer Genuine Aspirin", "product_id": "0924-6020_266e9c9f-2fab-071d-e063-6394a90aa179", "dosage_form": "TABLET", "pharm_class": ["Anti-Inflammatory Agents", "Non-Steroidal [CS]", "Cyclooxygenase Inhibitors [MoA]", "Decreased Platelet Aggregation [PE]", "Decreased Prostaglandin Production [PE]", "Nonsteroidal Anti-inflammatory Drug [EPC]", "Platelet Aggregation Inhibitor [EPC]"], "product_ndc": "0924-6020", "generic_name": "Aspirin", "labeler_name": "Acme United Corporation", "product_type": "HUMAN OTC DRUG", "brand_name_base": "Bayer Genuine Aspirin", "active_ingredients": [{"name": "ASPIRIN", "strength": "325 mg/1"}], "application_number": "M013", "marketing_category": "OTC MONOGRAPH DRUG", "marketing_start_date": "20230331", "listing_expiration_date": "20261231"}